Back to Top

PAN Foundation Launches HIV/AIDS Co-Pay Assistance Program

 

Washington, D.C., March 27, 2014 – PAN has launched the first cost-sharing assistance program for underinsured patients being treated for HIV/AIDS, providing a vital safety net program for patients who would otherwise not qualify for ADAP or manufacturer sponsored patient assistance. Until now, only government or manufacturer-sponsored assistance has been available for patients who are covered by insurance, but unable to afford the out-of-pocket costs associated with their HIV/AIDS medications.

"The need for access to life-saving medications for HIV/AIDS is strong, but until now, there has been a segment of the population who were still not able to afford their therapies," said Dr. Patrick McKercher, PAN President. "PAN is proud to address an unmet patient need in order to assist these patients in their life-long battle with Human Immunodeficiency Virus."

“Launching this program has long been a goal of the Foundation,” explained Korab Zuka, Vice President of External Relations & Patient Services. “As more HIV/AIDS patients age into Medicare – something we never thought possible – the need for foundation support becomes more prevalent than ever,” Zuka continued.

Qualifying patients will be eligible to receive up to $4,000 per year to help cover the out-of-pocket costs associated with their specialty medications for HIV/AIDS. To qualify, patients must have some form of insurance that covers the medication they are seeking assistance for, must reside and receive treatment in the United States and its territories, and must have a household income at or below 500% of the Federal Poverty Level ($78,650 for a family of two). To learn more, visit HIV Treatment and Prevention.

About the PAN Foundation

The Patient Access Network (PAN Foundation) is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed specialty medications. Since 2004, PAN has provided more than $400 million in financial assistance to more than 200,000 patients across nearly 60 disease-specific programs. To learn more, visit www.PANfoundation.org.

About Human Immunodeficiency Virus (HIV)

Human Immunodeficiency Virus, or HIV, is the virus that can lead to acquired immunodeficiency syndrome, or AIDS. Unlike some other viruses, the human body cannot get rid of HIV. That means that once you have HIV, you have it for life.

No safe and effective cure currently exists, but scientists are working hard to find one, and remain hopeful. Meanwhile, with proper medical care, HIV can be controlled. Treatment for HIV is often called antiretroviral therapy or ART. It can dramatically prolong the lives of many people infected with HIV and lower their chance of infecting others. Before the introduction of ART in the mid-1990s, people with HIV could progress to AIDS in just a few years. Today, someone diagnosed with HIV and treated before the disease is far advanced can have a nearly normal life expectancy.

HIV affects specific cells of the immune system, called CD4 cells, or T cells. Over time, HIV can destroy so many of these cells that the body can’t fight off infections and disease. When this happens, HIV infection leads to AIDS.